Myopia
Not recruitingStudy of atropine sulfate eye drops (0.
Study of atropine sulfate eye drops (0.
- Disease:Myopia
- Substances:Atropine Sulfate
Hungary- Participants:0–17 years
- Substances:Atropine Sulfate
- Sponsor:Ocumension (Hong Kong) Ltd.
Rare diseases
Investigational molecules
Locations
Back to Hungary498 clinical trials in Mohács, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of atropine sulfate eye drops (0.
HungaryStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis
HungaryStudy of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment
HungaryStudy of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety
HungaryStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
HungaryStudy on the Effectiveness and Safety of Iptacopan for Patients with Primary IgA Nephropathy
HungaryStudy on the Long-Term Safety and Efficacy of Paltusotine for Patients with Acromegaly
HungaryStudy Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients
HungaryStudy on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer
HungaryStudy Comparing the Effectiveness and Safety of Macitentan 75 mg and 10 mg for Patients with Pulmonary Arterial Hypertension
HungaryStudy of Atezolizumab and Tiragolumab for Patients with Recurrent or Metastatic PD-L1 Positive Head and Neck Squamous Cell Carcinoma
HungaryStudy on TIN816 for Preventing Acute Kidney Injury in Adults Undergoing Cardiac Surgery
HungaryThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical studies focusing on Crohn's Disease management, evaluating the long-term efficacy and safety of advanced therapeutic options. Research aims to improve maintenance therapy for patients with moderate to severe disease activity.
Comprehensive evaluation of novel treatment approaches for sustained disease control.
Comparative research examining the effectiveness of biosimilar therapies for moderate to severe ulcerative colitis. Studies focus on establishing therapeutic equivalence between traditional and newer treatment options.
Advanced research aimed at expanding treatment options for patients with inflammatory bowel conditions.
Investigation of new oral medications for treating moderately to severely active ulcerative colitis. Research focuses on achieving clinical remission through innovative therapeutic compounds.
Pioneering research to develop more convenient and effective treatment options for inflammatory bowel disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.